How often does Abeona Therapeutics move more than the options market prices?

0 of the last 8 reports moved at least as far as the implied move.

ABEONasdaqPharmaceutical Preparations

Abeona Therapeutics Inc. (ABEO) earnings date, market-implied expected move, and options open interest by expiry

4.24

−0.01 · −0.14%

post 4.24 0.00%

After hours16:00 ETdelayed

Open4.14Volume1.0MMkt cap$243.0MEPS-1.14

Day4.14 – 4.3844%52-wk4.00 – 7.657%

ABEO

Abeona Therapeutics Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 11

before open · in 8 days

est.Q3 FY26

Calendar

Next report

Last report

−14.95%

vs ±29.7% implied · ×0.50

shaded = implied · ▲▼ = realized

Aug 13 '26 · confirmed

Implied vs realized

Linked news

88dTSHA · customerTaysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

News

Largest filed tie

13F top-10 QoQ

+4.82%

shares held · 10 largest managers

13F · Jun 30 '26126d lag

126 managers

Top fund weight

0.01%

ABEO weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Abeona Therapeutics (ABEO) is expected to report on Nov 11 before open (estimated date).

Implied vs realized

8 reports

0 of 8≥ implied

avg implied: ±28.9%
avg realized: ±7.4%

Nov 14 '24Nov 14 '24confirmed±12.6%▼−2.46%×0.20

Mar 20 '25Mar 20 '25confirmed±43.6%▼−1.15%×0.03

May 15 '25May 15 '25confirmed±8.3%▲+7.42%×0.89

Aug 14 '25Aug 14 '25confirmed±28.8%▲+10.21%×0.35

Q3 FY25Nov 12 '25confirmed±41.4%▲+18.47%×0.45

Q1 FY26Mar 17 '26confirmed±44.6%▼−3.84%×0.09

May 13 '26May 13 '26confirmed±21.9%▲+0.53%×0.02

Q2 FY26Aug 13 '26confirmed±29.7%▼−14.95%×0.50

quarterimplied−45%0+45%realized×

Q2 FY26±29.7%▼−14.95%×0.50

May '26±21.9%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Oct 30 close

0.06OI · 4 expiries · Oct 30 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

46+188%Nov 2017d752+1%

8060%Dec 1845d0.098,8030%0.09

3,073+1%Jan 1573d0.644,8370%0.64

2,601+3%Mar 19136d1.861,402+1%1.86

ExpiryPutsCallsP/C

Nov 2017d46+188%752+1%0.06

Dec 1845d8060%8,8030%0.09

Jan 1573d3,073+1%4,8370%0.64

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−177.43%as filednet margin · revenue +30.50% QoQ · +2745.00% YoY

Revenue$11M+30.50%

Gross profit$7M63.30%+19.57%

Operating income−$14M−119.97%+40.72%

Pre-tax income−$20M−18.26%

Net income−$20M−177.43%−18.25%

Cost of revenue$4M+54.93%

Operating expenses$21M−28.22%

Tax$0−100.00%

Other expense−$7M−209.60%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

PPI ×1.40· ±3.8% vs ±2.7% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±3.8%6 of 10×1.40

PCEpersonal income & outlays±3.2%10 of 19×1.16

GDPgross domestic product±3.0%10 of 19×1.12

FOMCrate decision±2.7%10 of 24×0.99

NFPjobs report±2.6%6 of 10×0.95

CPROFcorporate profits±2.1%6 of 12×0.77

CPIconsumer prices±1.6%4 of 10×0.59

Bar = avg |move| to ±4% · tick = ±2.7% avg day · ×base = |move| ÷ ±2.7% · min 6 releases

Earnings history

EPS -0.35 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 13 '26 · confirmed	-0.35	—
Q1 FY26	Mar 17 '26 · confirmed	-0.30	—
Q3 FY25	Nov 12 '25 · confirmed	-0.10	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod